BioLineRx Ltd.
BLRX | TA
Overview
Corporate Details
- ISIN(s):
- US09071M2052 (+1 more)
- LEI:
- 529900AKIOSC15Y63R18
- Country:
- Israel
- Address:
- Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
- Website:
- https://www.biolinerx.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BioLineRx Ltd. develops and commercializes therapies for oncology and other critical diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 01:25 |
Takeover Announcement Report
Immediate Report
|
English | 127.3 KB | |
| 2025-07-01 01:25 |
Regulatory News Service
Immediate Report
|
English | 36.5 KB | |
| 2025-05-30 17:23 |
Takeover Announcement Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
|
English | 153.1 KB | |
| 2025-05-30 17:23 |
Regulatory News Service
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
|
English | 36.4 KB | |
| 2025-05-27 16:01 |
Regulatory News Service
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
|
English | 430.8 KB | |
| 2025-05-27 16:01 |
Earnings Release
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
|
English | 36.4 KB | |
| 2025-05-24 23:14 |
Proxy Solicitation & Information Statements
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 160.1 KB | |
| 2025-05-24 23:14 |
Regulatory News Service
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 534.4 KB | |
| 2025-05-24 23:14 |
Declaration of Voting Results & Voting Rights Announcements
Immediate Report of Meeting to be held on June 29,2025,proxy statement
|
English | 100.8 KB | |
| 2025-04-14 13:22 |
Prospectus
PROSPECTUS SUPPLEMENT
|
English | 415.1 KB | |
| 2025-04-14 13:22 |
Prospectus
PROSPECTUS SUPPLEMENT
|
English | 36.2 KB | |
| 2025-03-31 16:06 |
Regulatory News Service
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
|
English | 1.5 MB | |
| 2025-03-31 16:06 |
Regulatory News Service
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
|
English | 36.3 KB | |
| 2025-03-31 16:06 |
Takeover Announcement Report
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
|
English | 192.4 KB | |
| 2025-03-31 16:06 |
Report Publication Announcement
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
|
English | 36.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |